Khattar Jack A.

CIK 00015399371 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001539937

Recent Transactions

24 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−14,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−38,640→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+14,000→ 960,245 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−6,666→ 953,579 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+38,640→ 964,812 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−18,567→ 946,245 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−14,000→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−6,666→ 953,579 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+14,000→ 960,245 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−38,640→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−18,567→ 946,245 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+38,640→ 964,812 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-11-25−17,794→ 125,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-11-25−17,794→ 125,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-25$35.18/sh−11,135→ 789,434 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-25$35.18/sh−11,135→ 789,434 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-25$9.56/sh+17,794→ 800,569 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-25$9.56/sh+17,794→ 800,569 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-23$35.05/sh−2,259→ 782,775 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-11-23−3,616→ 142,794 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-23$35.05/sh−2,259→ 782,775 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-23$9.56/sh+3,616→ 785,034 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-11-23−3,616→ 142,794 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-11-23$9.56/sh+3,616→ 785,034 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
Director, President, CEO
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov